DOSSIERS / FOCUS CLINICAL DRUG DEVELOPMENT GMBH
← SearchExport PDF
Company dossier

FOCUS Clinical Drug Development GmbH

GERMANY · COMPANY
KYBE ID: DE-R1102_HRB6900 · R1102_HRB6900 · 1 sources
RISK SCORE16LOW RISK

Key facts

active
FOCUS Clinical Drug Development GmbH
de
R1102_HRB6900
de
active
de
Stresemannallee 6, 41460 Neuss.
de

Companies at this address

14 total

Connections

30 links
Showing 15 of 30 — full graph via /v1/entities/DE-R1102_HRB6900/network.

People with significant control

13 people
NameRoleFromSource
Dietrich Doctor BruchmannAuthorized representativeGermany registry
Antal Doctor Hajosmit der Befugnis im Namen der Gesellschaft mit sich als VertGermany registry
Antal Hajosmit der Befugnis im Namen der Gesellschaft mit sich als VertGermany registry
Antal Doctor HajosofficerGermany registry
Christian Doctor RehofficerGermany registry
Claudia Doctor HesselmannofficerGermany registry
Dietrich Doctor BruchmannofficerGermany registry
Jean-Philip BelekeofficerGermany registry
Manuel BartschtofficerGermany registry
Markus Prof. Doctor MeyerofficerGermany registry
Matthias Doctor BaumannofficerGermany registry
Reinhold SchäffelerofficerGermany registry
Roswitha Margarete Vogt-SchenkelofficerGermany registry

Risk signals

1 matched
high

Business fragmentation

A director is shared across 26 companies — business-splitting (дробление) pattern

Risk journey — why 16?

1 signals
+16
Business fragmentation
Composite risk score16/100